Rare diseases
Investigational molecules
Locations
Back to Italy1 clinical trial in Ortona, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)ItalyThe busiest research cities in the country
What the registry says about research in the country
Investigating optimal treatment strategies for endocrine-responsive early breast cancer in post-menopausal patients, focusing on the timing of combination therapies.
This significant research examines the effectiveness of sequential versus concurrent administration of chemotherapy and aromatase inhibitors, aiming to prevent disease recurrence in early-stage breast cancer patients.
Exploring treatment protocols for hormone-responsive tumors, which represent approximately 80% of breast cancer cases in North America, Europe, and Latin America.
The research aims to establish optimal timing strategies for combining endocrine therapy with conventional chemotherapy treatments.
Conducting comprehensive research on disease recurrence prevention in early-stage breast cancer, with a focus on post-menopausal patients.
This research specifically addresses the integration of multiple treatment modalities to achieve optimal therapeutic outcomes in breast cancer patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
